Clinical Trials Directory

Trials / Completed

CompletedNCT03816813

Assessement of Hepcidin in Saliva in Human Volunteers

Detection of Hepcidin in Saliva and Its Utility as a Diagnostic Marker for Iron Deficiency

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Swiss Federal Institute of Technology · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers

Summary

Iron deficiency with or without anemia is considered the most widespread nutritional deficiency in the world. To diagnose iron deficiency anemia (hemoglobin and ferritin measurement), a venous blood sample is necessary. Whole saliva is a potentially attractive fluid for disease biomarker discovery and diagnostic efforts, because it is readily available from most individuals, can be easily collected and the collection procedure is non-invasive. The iron storage protein ferritin is too big, to be secreted into saliva. However, the main iron regulatory protein hepcidin is a very small protein and there is some evidence for hepcidin detection in saliva. The production of serum hepcidin positively correlates with serum ferritin, thereby reflecting patient's iron status. Whether hepcidin is detectable in saliva and whether saliva hepcidin correlates with serum hepcidin with current assays, needs to be tested.

Conditions

Interventions

TypeNameDescription
OTHERblood and saliva samplingblood and saliva sampling

Timeline

Start date
2019-02-04
Primary completion
2019-02-07
Completion
2019-02-07
First posted
2019-01-25
Last updated
2019-03-22

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03816813. Inclusion in this directory is not an endorsement.